Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon

Analyse de l'application OzemPro: Lose Weight on GLP-1 pour le 1 octobre

OzemPro: Lose Weight on GLP-1

OzemPro: Lose Weight on GLP-1

  • FitCal LTDA
  • Google Play Store
  • Gratuit
  • Santé & Fitness
Your whole GLP-1 treatment in one app: injections, dose, side effects, weight, food, and progress. OzemPro is the digital journal for people on GLP-1 medication. Every day and every week logged, organized, and ready to review or bring to your doctor. WHO IT'S FOR For anyone on Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Saxenda®, Trulicity®, Rybelsus®, semaglutide, tirzepatide, liraglutide, dulaglutide, or any other GLP-1 medication — by pen, by vial and syringe, or in tablet form. Compounded and generic versions included. And for anyone who wants the treatment under control: track every injection, follow side effects and weight loss closely, and stop keeping it all in notes, screenshots, and memory. KEY FEATURES • Injections and pens: day, dose, injection site and rotation, with a full history of every week on Ozempic, Mounjaro, Wegovy, Zepbound, or a generic • Injection reminders: alerts at the right time, so you never miss your weekly dose • My stock: how many doses are left in the pen you're using, with an alert when it's running low • Dose calculator: for vials and syringes, how many units to draw for your dose, with a table to save and share • Medication level: your estimated concentration through the week, up to the next dose • Side effects: nausea, constipation, reflux, and whatever else shows up, with educational guidance on what usually helps • Weight, BMI, and body composition: charts that show the curve, not just today's number • Goal projection: how much is left and when you'll get there, at your current pace • Personalized plan: calorie, macro, weight, and water goals calculated from your profile and your goal • Meals by photo, voice, or text: calories, protein, carbs, fat, and fiber • Meal plan: meals calculated for your goals, with options to swap any dish • Recipes: ingredients and step-by-step for every dish in your meal plan • Supplements and vitamins: a daily checklist of what you take alongside your medication, with reminders • Water and daily steps: the habits that hold results together between injections • Journey card: progress photos, measurements, and milestones across your treatment • Community: join public groups or start your own with an invite code, post, comment, and follow the streak and progress leaderboards, plus health news • AI chat: ask about your treatment routine, with the sources behind every answer • Widget: your dose and daily goals on the home screen • Health Connect: syncs weight, steps, workouts, and hydration • PDF report: bring your complete treatment history to your appointment NON-AFFILIATION NOTICE OzemPro is an independent app, not affiliated with, sponsored by, or endorsed by Novo Nordisk, Eli Lilly, or any pharmaceutical company. Ozempic, Wegovy, Saxenda, and Rybelsus are registered trademarks of Novo Nordisk A/S; Mounjaro, Zepbound, and Trulicity of Eli Lilly and Company. All trademarks belong to their respective owners and appear only as examples of GLP-1 medications, for informational purposes. IMPORTANT NOTICE OzemPro is a tracking and educational support tool. It does not provide diagnosis, prescription, medical advice, or treatment, and it is not a substitute for guidance from your healthcare provider. The dose calculator converts volume from the values you enter: it does not set or recommend a dose. Always consult your doctor before any decision about your GLP-1 treatment. SUBSCRIPTION Full access requires a monthly or annual auto-renewing subscription. There is no free version with full access to features. Prices are shown in the app before you confirm. Payment is charged to your Google Play account and renews automatically unless cancelled at least 24 hours before the end of the current period. Manage or cancel in Google Play, under Payments and subscriptions. Privacy Policy: https://www.ozempro.com/en/privacy-policy OzemPro Terms of Service: https://www.ozempro.com/en/terms-of-use
OzemPro: Lose Weight on GLP-1

Rang d'utilisation de OzemPro: Lose Weight on GLP-1

Le classement d'utilisation est basé sur l'algorithme de Similarweb qui calcule les installations actuelles et les utilisateurs actifs sur une période de 28 jours.

Toutes les catégories dans
États-Unis--
Santé & Fitness dans
États-Unis--

Utilisateurs actifs quotidiens

Analysez les habitudes d'utilisation des utilisateurs de OzemPro: Lose Weight on GLP-1 en consultant les téléchargements de OzemPro: Lose Weight on GLP-1 et les utilisateurs actifs quotidiens au fil du temps.

Utilisateurs

Analysez les habitudes d'utilisation des utilisateurs de OzemPro: Lose Weight on GLP-1 en consultant les téléchargements de OzemPro: Lose Weight on GLP-1 et les utilisateurs actifs quotidiens au fil du temps.

Unlock daily active users
aoûtsept.oct.

Statistiques de classement dans le temps pour OzemPro: Lose Weight on GLP-1

Classement d'utilisation et classement Google Play Store de Similarweb pour OzemPro: Lose Weight on GLP-1

Classement d'utilisation

Classement

Ranking par pays pour OzemPro: Lose Weight on GLP-1

Pays dans lesquels OzemPro: Lose Weight on GLP-1 est le mieux classé dans ses principales catégories


Intérêts des utilisateurs & catégories principales

Principales catégories et applications utilisées par les utilisateurs de OzemPro: Lose Weight on GLP-1

Aucune donnée à afficher

Principaux concurrents & apps alternatives

Applications ayant une forte probabilité d'être utilisées par les mêmes utilisateurs, à partir du même store.

Keto Manager: Low Carb Diet

Keto Manager: Low Carb Diet

Pixster Studio

Kompanion Intermittent Fasting

Kompanion Intermittent Fasting

Ornitorenk Dijital Hizmetler Anonim Sirketi

Intermittent Fasting: FastEasy

Intermittent Fasting: FastEasy

WELLTECH APPS LIMITED

AI Calorie Counter: Nutrilio

AI Calorie Counter: Nutrilio

Habitics

OzemPro: Lose Weight on GLP-1 VS.

octobre 1, 2026